Furthermore, survival analysis indicated that patients with low levels of miR‐138‐5p suffered poorer OS in the early stage group and in the advanced stage group, respectively, but both the differences did not reach statistical significance, which might be due to limitation in sample size (Figure S1B,C ).
← all excerpts
miR-138-5p targets MCU to inhibit mitochondrial biogenesis and colorectal cancer growth.
1
—
—